INM logo

InMed Pharmaceuticals Inc. (INM)

Profile

Full Name

InMed Pharmaceuticals Inc.

Ticker

NASDAQ: INM

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

Canada

IPO

May 5, 2014

Indexes

Not included

Website

https://www.inmedpharma.com

Employees

13

Key Details

Price

$1.23(-15.75%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$4.94M(7.50% YoY)

Annual EPS

-$8.36(58.48% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.23
    INM price is $1.23

    30-Day Relative Volume

    12.27
    INM 30-day relative volume is 12.27

    Price Performance

    Price Most Recent Change

    -15.75%
    INM price was down -15.75% on Nov 19, 2025

    Price YTD Change

    -74.05%
    INM price is down -74.05% since January 1st

    Price 1-Year Change

    -71.72%
    INM price is down -71.72% year-on-year

    Price 3-Year Change

    -97.77%
    INM price is down -97.77% over the past 3 years

    Price Range

    Price All-Time High

    $32175.00
    INM price is currently -100.00% below its historical high of $32175.00

    Price 3-Year Low

    $1.23
    INM price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $3.45M
    INM market cap is $3.45 million

    Market Cap 3-Year Change

    +33.51%
    INM market cap is up +33.51% over the past 3 years

    Market Cap All-Time High

    $252.60M
    INM market cap is currently -98.63% below its historical high of $252.60 million

    Market Cap Sector Percentile

    8.87%
    INM market cap is higher than 8.87% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +290.5%
    INM shares outstanding is up +290.5% year-on-year

    Shares Outstanding 3-Year Change

    +5891.88%
    INM shares outstanding is up +5891.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.16
    INM beta is 1.16

    200-day SMA

    $2.53
    INM price is currently -51.32% below its 200-day simple moving average

    50-day SMA

    $2.04
    INM price is currently -39.63% below its 50-day simple moving average

    14-Day RSI

    22.43
    INM 14-day relative strength index is 22.43

    Volume

    12.27
    INM 30-day relative volume is 12.27

    ATR

    $0.13
    INM average true range is $0.13

    10-day Historical Volatility

    111.71%
    INM 10-day historical volatility is 111.71%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.94M
    INM annual revenue is $4.94 million

    Revenue Analysts Estimate

    $71.00M
    INM annual revenue is currently -93.04% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +7.5%
    INM annual revenue is up +7.5% year-on-year

    Revenue Sector Percentile

    43.65%
    INM annual revenue is higher than 43.65% of companies in Healthcare sector

    EPS

    EPS

    -$8.36
    INM annual earnings per share is -$8.36

    EPS Analysts Estimate

    -
    INM annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    +58.48%
    INM annual earnings per share is up +58.48% year-on-year

    EPS Sector Percentile

    16.45%
    INM annual earnings per share is higher than 16.45% of companies in Healthcare sector

    Profit

    Gross Profit

    $1.17M
    INM annual gross profit is $1.17 million

    Gross Margin

    23.71%
    INM annual gross profit margin is 23.71%

    Operating Profit

    -$7.92M
    INM annual operating income is -$7.92 million

    Operating Margin

    -160.20%
    INM annual operating profit margin is -160.20%

    Net Income

    -$8.16M
    INM annual net profit is -$8.16 million

    Net Margin

    -165.14%
    INM annual net profit margin is -165.14%

    Expenses

    Total Expenses

    $13.10M
    INM annual total expenses is $13.10 million

    Operating Expenses

    $9.09M
    INM annual total operating expenses is $9.09 million

    Cost Of Goods Sold

    $3.77M
    INM annual cost of goods sold is $3.77 million

    Selling, General & Administrative Expenses

    $0.00
    INM annual SG&A is $0.00

    Depreciation & Amortization

    $534.70K
    INM annual D&A is $534.70 thousand

    Interest Expense

    $0.00
    INM annual interest expense is $0.00

    Income Tax

    $0.00
    INM annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$7.92M
    INM annual earnings before interest & taxes is -$7.92 million

    EBITDA

    -$7.38M
    INM annual EBITDA is -$7.38 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $15.58M
    INM annual total assets is $15.58 million

    Non Current Assets

    $2.71M
    INM annual long term assets is $2.71 million

    Current Assets

    $12.87M
    INM annual total current assets is $12.87 million

    Cash and Cash Equivalents

    $11.12M
    INM annual cash & cash equivalents is $11.12 million

    Accounts Receivable

    $465.10K
    INM annual accounts receivable is $465.10 thousand

    Inventory

    $961.20K
    INM annual inventory is $961.20 thousand

    Liabilities

    Total Liabilities

    $2.15M
    INM annual total liabilities is $2.15 million

    Long Term Liabilities

    $305.70K
    INM annual total long term liabilities is $305.70 thousand

    Current Liabilities

    $1.84M
    INM annual current liabilities is $1.84 million

    Accounts Payable

    $370.10K
    INM annual accounts payable is $370.10 thousand

    Debt

    Total Debt

    $741.30K
    INM annual total debt is $741.30 thousand

    Total Debt 1-Year Change

    -23%
    INM annual total debt is down -23% year-on-year

    Long Term Debt

    $305.80K
    INM annual long term debt is $305.80 thousand

    Short Term Debt

    $435.50K
    INM annual short term debt is $435.50 thousand

    Equity & Capital

    Shareholders Equity

    $13.43M
    INM annual stockholders equity is $13.43 million

    Book Value

    $13.43M
    INM annual book value is $13.43 million

    Retained Earnings

    -$117.24M
    INM annual retained earnings is -$117.24 million

    Working Capital

    $11.03M
    INM annual working capital is $11.03 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$7.77M
    INM annual cash from operations is -$7.77 million

    Cash From Operations 1-Year Change

    -11.18%
    INM annual cash from operations is down -11.18% year-on-year

    Cash From Investing

    $0.00
    INM annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    +100%
    INM annual cash from investing is up +100% year-on-year

    Cash From Financing

    $12.27M
    INM annual cash from financing is $12.27 million

    Cash From Financing 1-Year Change

    +163.66%
    INM annual cash from financing is up +163.66% year-on-year

    CAPEX

    CAPEX

    $0.00
    INM annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -100%
    INM annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$7.77M
    INM annual free cash flow is -$7.77 million

    Free Cash Flow 1-Year Change

    -11.03%
    INM annual free cash flow is down -11.03% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    23.71%
    INM annual gross profit margin is 23.71%

    Operating Margin

    -160.20%
    INM annual operating profit margin is -160.20%

    Net Margin

    -165.14%
    INM annual net profit margin is -165.14%

    ROA & ROE

    ROA

    -59.57%
    INM annual return on assets is -59.57%

    ROE

    -72.10%
    INM annual return on equity is -72.10%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    INM price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    INM price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.30
    INM price to book ratio is 0.30

    PB Ratio Sector Percentile

    22.07%
    INM price to book ratio is higher than 22.07% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.72
    INM price to sales ratio is 0.72

    PS Ratio Sector Percentile

    17.77%
    INM price to sales ratio is higher than 17.77% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    -$5.28M
    INM enterprise value is -$5.28 million

    Enterprise Value Sector Percentile

    6.54%
    INM enterprise value is higher than 6.54% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.72
    INM EV/EBITDA is 0.72

    EV/EBITDA Sector Percentile

    70.68%
    INM EV/EBITDA is higher than 70.68% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.99
    INM annual current ratio is 6.99

    Quick Ratio

    6.47
    INM annual quick ratio is 6.47

    Leverage

    Debt To Equity

    0.06
    INM annual debt to equity ratio is 0.06

    Interest Coverage Ratio

    -
    INM annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    INM piotroski f-score is 4

    Altman Z-Score

    -10.08
    INM altman z-score is -10.08

    Analyst ratings

    Recent major analysts updates

    Dec 22, 21 HC Wainwright & Co.
    Buy
    Nov 29, 21 HC Wainwright & Co.
    Buy
    Feb 16, 21 Roth Capital
    Buy

    Institutional Ownership

    Screeners with INM included

    Growing Shares Outstanding
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for InMed Pharmaceuticals Inc.?
    • Does InMed Pharmaceuticals Inc. pay dividends?
    • What sector is InMed Pharmaceuticals Inc. in?
    • What industry is InMed Pharmaceuticals Inc. in?
    • What country is InMed Pharmaceuticals Inc. based in?
    • When did InMed Pharmaceuticals Inc. go public?
    • Is InMed Pharmaceuticals Inc. in the S&P 500?
    • Is InMed Pharmaceuticals Inc. in the NASDAQ 100?
    • Is InMed Pharmaceuticals Inc. in the Dow Jones?
    • When was InMed Pharmaceuticals Inc.'s last earnings report?
    • When does InMed Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for InMed Pharmaceuticals Inc.?

    The ticker symbol for InMed Pharmaceuticals Inc. is NASDAQ:INM

    Does InMed Pharmaceuticals Inc. pay dividends?

    No, InMed Pharmaceuticals Inc. does not pay dividends

    What sector is InMed Pharmaceuticals Inc. in?

    InMed Pharmaceuticals Inc. is in the Healthcare sector

    What industry is InMed Pharmaceuticals Inc. in?

    InMed Pharmaceuticals Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is InMed Pharmaceuticals Inc. based in?

    InMed Pharmaceuticals Inc. is headquartered in Canada

    When did InMed Pharmaceuticals Inc. go public?

    InMed Pharmaceuticals Inc.'s initial public offering (IPO) was on May 5, 2014

    Is InMed Pharmaceuticals Inc. in the S&P 500?

    No, InMed Pharmaceuticals Inc. is not included in the S&P 500 index

    Is InMed Pharmaceuticals Inc. in the NASDAQ 100?

    No, InMed Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is InMed Pharmaceuticals Inc. in the Dow Jones?

    No, InMed Pharmaceuticals Inc. is not included in the Dow Jones index

    When was InMed Pharmaceuticals Inc.'s last earnings report?

    InMed Pharmaceuticals Inc.'s most recent earnings report was on September 30, 2025

    When does InMed Pharmaceuticals Inc. report earnings?

    The date for InMed Pharmaceuticals Inc.'s next earnings report has not been announced yet
    On this page